Literature DB >> 10456881

Cloning and molecular characterization of plasmid-encoded antigens of Borrelia burgdorferi.

J T Skare1, D M Foley, S R Hernandez, D C Moore, D R Blanco, J N Miller, M A Lovett.   

Abstract

Thirteen independent clones that encode Borrelia burgdorferi antigens utilizing antiserum from infection-immune rabbits were identified. The serum was adsorbed against noninfectious B. burgdorferi B31 to enrich for antibodies directed against either infection-associated antigens of B. burgdorferi B31 or proteins preferentially expressed during mammalian infection. The adsorption efficiency of the immune rabbit serum (IRS) was assessed by Western immunoblot analysis with protein lysates derived from infectious and noninfectious B. burgdorferi B31. The adsorbed IRS was used to screen a B. burgdorferi expression library to identify immunoreactive phage clones. Clones were then expressed in Escherichia coli and subsequently analyzed by Western blotting to determine the molecular mass of the recombinant B. burgdorferi antigens. Southern blot analysis of the 13 clones indicated that 10 contained sequences unique to infectious B. burgdorferi. Nucleotide sequence analysis indicated that the 13 clones were composed of 9 distinct genetic loci and that all of the genes identified were plasmid encoded. Five of the clones carried B. burgdorferi genes previously identified, including those encoding decorin binding proteins A and B (dbpAB), a rev homologue present on the 9-kb circular plasmid (cp9), a rev homologue from the 32-kb circular plasmid (cp32-6), erpM, and erpX. Additionally, four previously uncharacterized loci with no known homologues were identified. One of these unique clones encoded a 451-amino-acid lipoprotein with 21 consecutive, invariant 9-amino-acid repeats near the amino terminus that we have designated VraA (for "virulent strain-associated repetitive antigen A"). Since all the antigens identified are recognized by serum from infection immune rabbits, these antigens represent potential vaccine candidates and, based on the identification of dbpAB in this screen, may also be involved in pathogenic processes operative in Lyme borreliosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10456881      PMCID: PMC96759     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium.

Authors:  L H Sigal; J M Zahradnik; P Lavin; S J Patella; G Bryant; R Haselby; E Hilton; M Kunkel; D Adler-Klein; T Doherty; J Evans; P J Molloy; A L Seidner; J R Sabetta; H J Simon; M S Klempner; J Mays; D Marks; S E Malawista
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo.

Authors:  R Wallich; C Brenner; M D Kramer; M M Simon
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

4.  The Mycoplasma hominis vaa gene displays a mosaic gene structure.

Authors:  T Boesen; J Emmersen; L T Jensen; S A Ladefoged; P Thorsen; S Birkelund; G Christiansen
Journal:  Mol Microbiol       Date:  1998-07       Impact factor: 3.501

5.  Passive immunization of hamsters against experimental infection with the Lyme disease spirochete.

Authors:  R C Johnson; C Kodner; M Russell
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

6.  Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities.

Authors:  A C Steere; S E Malawista; D R Snydman; R E Shope; W A Andiman; M R Ross; F M Steele
Journal:  Arthritis Rheum       Date:  1977 Jan-Feb

7.  DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies.

Authors:  D R Cassatt; N K Patel; N D Ulbrandt; M S Hanson
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

8.  Lyme carditis: cardiac abnormalities of Lyme disease.

Authors:  A C Steere; W P Batsford; M Weinberg; J Alexander; H J Berger; S Wolfson; S E Malawista
Journal:  Ann Intern Med       Date:  1980-07       Impact factor: 25.391

9.  Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation.

Authors:  T G Schwan; W Burgdorfer; C F Garon
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

10.  Isolation and cultivation of Lyme disease spirochetes.

Authors:  A G Barbour
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  24 in total

1.  Mutation and recombination in the upstream homology box-flanked ospE-related genes of the Lyme disease spirochetes result in the development of new antigenic variants during infection.

Authors:  S Y Sung; J V McDowell; J A Carlyon; R T Marconi
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Identification of 11 pH-regulated genes in Borrelia burgdorferi localizing to linear plasmids.

Authors:  J A Carroll; R M Cordova; C F Garon
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 3.  Spirochaetal lipoproteins and pathogenesis.

Authors:  D A Haake
Journal:  Microbiology       Date:  2000-07       Impact factor: 2.777

4.  A second allele of eppA in Borrelia burgdorferi strain B31 is located on the previously undetected circular plasmid cp9-2.

Authors:  J C Miller; J L Bono; K Babb; N El-Hage; S Casjens; B Stevenson
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

5.  Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins.

Authors:  Andrew J Nowalk; Robert D Gilmore; James A Carroll
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

6.  The BBA33 lipoprotein binds collagen and impacts Borrelia burgdorferi pathogenesis.

Authors:  Hui Zhi; Eric H Weening; Elena Magda Barbu; Jenny A Hyde; Magnus Höök; Jon T Skare
Journal:  Mol Microbiol       Date:  2015-01-30       Impact factor: 3.501

7.  Examination of the Borrelia burgdorferi transcriptome in Ixodes scapularis during feeding.

Authors:  Sukanya Narasimhan; Felix Santiago; Raymond A Koski; Brandon Brei; John F Anderson; Durland Fish; Erol Fikrig
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

8.  Changes in bacterial growth rate govern expression of the Borrelia burgdorferi OspC and Erp infection-associated surface proteins.

Authors:  Brandon L Jutras; Alicia M Chenail; Brian Stevenson
Journal:  J Bacteriol       Date:  2012-12-07       Impact factor: 3.490

9.  The BosR regulatory protein of Borrelia burgdorferi interfaces with the RpoS regulatory pathway and modulates both the oxidative stress response and pathogenic properties of the Lyme disease spirochete.

Authors:  Jenny A Hyde; Dana K Shaw; Roger Smith Iii; Jerome P Trzeciakowski; Jon T Skare
Journal:  Mol Microbiol       Date:  2009-11-10       Impact factor: 3.501

10.  Dissolved oxygen levels alter gene expression and antigen profiles in Borrelia burgdorferi.

Authors:  J Seshu; Julie A Boylan; Frank C Gherardini; Jonathan T Skare
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.